121 related articles for article (PubMed ID: 9498471)
1. Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies.
Conti S; Fanti F; Magliani W; Gerloni M; Bertolotti D; Salati A; Cassone A; Polonelli L
J Infect Dis; 1998 Mar; 177(3):807-11. PubMed ID: 9498471
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.
Polonelli L; Séguy N; Conti S; Gerloni M; Bertolotti D; Cantelli C; Magliani W; Cailliez JC
Clin Diagn Lab Immunol; 1997 Mar; 4(2):142-6. PubMed ID: 9067647
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis carinii.
Séguy N; Cailliez JC; Delcourt P; Conti S; Camus D; Dei-Cas E; Polonelli L
Mol Med; 1997 Aug; 3(8):544-52. PubMed ID: 9307982
[TBL] [Abstract][Full Text] [Related]
4. Human natural yeast killer toxin-like candidacidal antibodies.
Polonelli L; De Bernadis F; Conti S; Boccanera M; Magliani W; Gerloni M; Cantelli C; Cassone A
J Immunol; 1996 Mar; 156(5):1880-5. PubMed ID: 8596040
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by yeast killer toxin-like antibodies of oral Streptococci adhesion to tooth surfaces in an ex vivo model.
Conti S; Magliani W; Arseni S; Frazzi R; Salati A; Ravanetti L; Polonelli L
Mol Med; 2002 Jun; 8(6):313-7. PubMed ID: 12428062
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant gram-positive cocci.
Conti S; Magliani W; Arseni S; Dieci E; Frazzi R; Salati A; Varaldo PE; Polonelli L
Mol Med; 2000 Jul; 6(7):613-9. PubMed ID: 10997342
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.
Magliani W; Conti S; de Bernardis F; Gerloni M; Bertolotti D; Mozzoni P; Cassone A; Polonelli L
Nat Biotechnol; 1997 Feb; 15(2):155-8. PubMed ID: 9035141
[TBL] [Abstract][Full Text] [Related]
8. Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade.
Polonelli L; Beninati C; Teti G; Felici F; Ciociola T; Giovati L; Sperindè M; Lo Passo C; Pernice I; Domina M; Arigò M; Papasergi S; Mancuso G; Conti S; Magliani W
PLoS One; 2014; 9(8):e105727. PubMed ID: 25162681
[TBL] [Abstract][Full Text] [Related]
9. Yeast killer toxin-like anti-idiotypic antibodies.
Polonelli L; Morace G
J Clin Microbiol; 1988 Mar; 26(3):602-4. PubMed ID: 2451680
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of yeast killer toxin-like antibodies and mimotopes.
Magliani W; Conti S; Salati A; Vaccari S; Ravanetti L; Maffei DL; Polonelli L
FEMS Yeast Res; 2004 Oct; 5(1):11-8. PubMed ID: 15381118
[TBL] [Abstract][Full Text] [Related]
11. Effect of a killer toxin of Pichia anomala to Pneumocystis. Perspectives in the control of pneumocystosis.
Séguy N; Polonelli L; Dei-Cas E; Cailliez JC
FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):145-9. PubMed ID: 9792073
[TBL] [Abstract][Full Text] [Related]
12. Killer anti-idiotypes in the control of fungal infections.
Magliani W; Conti S; Arseni S; Frazzi R; Salati A; Polonelli L
Curr Opin Investig Drugs; 2001 Apr; 2(4):477-9. PubMed ID: 11566002
[TBL] [Abstract][Full Text] [Related]
13. From yeast killer toxins to antibiobodies and beyond.
Magliani W; Conti S; Travassos LR; Polonelli L
FEMS Microbiol Lett; 2008 Nov; 288(1):1-8. PubMed ID: 18785931
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.
Manfredi M; McCullough MJ; Conti S; Polonelli L; Vescovi P; Al-Karaawi ZM; Porter SR
Oral Microbiol Immunol; 2005 Aug; 20(4):226-32. PubMed ID: 15943767
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.
Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
Antimicrob Agents Chemother; 2006 Sep; 50(9):3090-7. PubMed ID: 16940106
[TBL] [Abstract][Full Text] [Related]
16. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.
Polonelli L; De Bernardis F; Conti S; Boccanera M; Gerloni M; Morace G; Magliani W; Chezzi C; Cassone A
J Immunol; 1994 Mar; 152(6):3175-82. PubMed ID: 8144911
[TBL] [Abstract][Full Text] [Related]
17. Killer toxin secretion through the cell wall of the yeast Pichia anomala.
Cailliez JC; Cantelli C; Séguy N; Conti S; Gerloni M; Morace G; Polonelli L
Mycopathologia; 1994 Jun; 126(3):173-7. PubMed ID: 7935732
[TBL] [Abstract][Full Text] [Related]
18. Serological study of yeast killer toxins by monoclonal antibodies.
Polonelli L; Manzara S; Conti S; Dettori G; Morace G; Chezzi C
Mycopathologia; 1989 Dec; 108(3):211-5. PubMed ID: 2515441
[TBL] [Abstract][Full Text] [Related]
19. A transphyletic anti-infectious control strategy based on the killer phenomenon.
Conti S; Magliani W; Gerloni M; Salati A; Dieci E; Arseni S; Fisicaro P; Polonelli L
FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):151-61. PubMed ID: 9792074
[TBL] [Abstract][Full Text] [Related]
20. Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans.
Polonelli L; Fanti F; Conti S; Campani L; Gerloni M; Castagnola M; Morace G; Chezzi C
J Immunol Methods; 1990 Sep; 132(2):205-9. PubMed ID: 2170534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
